Hirudin Attenuates Uric Acid‐Induced Renal Tubular Injury via TNFRSF6B ‐Mediated Suppression of NF ‐ κB Signaling
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 31.07.2026. Verfasst von Yingxue Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: Hirudins, NF-kappa B, Kidney Tubules. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Natural Science Foundation, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Hyperuricemia, characterized by elevated serum uric acid (SUA) levels, is increasingly recognized as a pathological contributor to renal injury through oxidative stress, inflammation, and apoptosis. Hirudin, a thrombin inhibitor derived from leech saliva, has recently been noted for its anti‐inflammatory properties, yet its role in hyperuricemia remains unclear. This study aimed to investigate the protective effects and underlying mechanisms of hirudin in a uric acid (UA)‐induced renal tubular epithelial injury model. Using HK‐2 cells, we found that hirudin enhanced cell viability and reduced apoptosis in UA‐treated conditions. Mechanistically, these protective effects were mediated through downregulation of TNFRSF6B, a decoy receptor involved in inflammatory and apoptotic signaling. TNFRSF6B knockdown potentiated hirudin's cytoprotective effects, whereas its overexpression reversed them. Hirudin treatment attenuated UA‐induced expression of urate transporters (URAT1, GLUT9, and OAT4) and pro‐inflammatory cytokine IL‐1β, both at the transcriptional and protein levels. Moreover, hirudin suppressed activation of the NF‐κB signaling pathway, a critical mediator of inflammation and apoptosis in hyperuricemia, with transcriptomic and immunoblotting data confirming downregulation of NF‐κB‐associated targets. Co‐treatment with JSH‐23, an NF‐κB inhibitor, further reinforced these findings and highlighted a TNFRSF6B/NF‐κB axis as a key regulatory mechanism. Collectively, these findings reveal a novel protective role for hirudin in UA‐induced renal injury, mediated via modulation of TNFRSF6B and suppression of NF‐κB signaling. This study provides new insight into the potential therapeutic application of hirudin in hyperuricemia‐associated kidney damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Guangxi Keyken Technology Group Co., Ltd., Nanning, China.
- GuangXi Health Science College, Nanning, China.
ORCID-Profile: Yingxue Zhao, Yongjie Qin, Xihua Liu
Förderung
- Guangxi Natural Science Foundation
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Zhao, Y., Qin, Y., He, L., Luo, H., Mo, Y., Zhou, W., He, H., Zhou, G., & Liu, X. (2026). Hirudin Attenuates Uric Acid‐Induced Renal Tubular Injury via TNFRSF6B ‐Mediated Suppression of NF ‐ κB Signaling. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70305
Vancouver
Zhao Y, Qin Y, He L, Luo H, Mo Y, Zhou W, et al. Hirudin Attenuates Uric Acid‐Induced Renal Tubular Injury via TNFRSF6B ‐Mediated Suppression of NF ‐ κB Signaling. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70305
BibTeX
@article{Zhao2026,
author = {Zhao, Yingxue and Qin, Yongjie and He, Lanzhi and Luo, Haikun and Mo, Ying and Zhou, Weihai and He, Huamei and Zhou, Ganping and Liu, Xihua},
title = {Hirudin Attenuates Uric Acid‐Induced Renal Tubular Injury via TNFRSF6B ‐Mediated Suppression of NF ‐ κB Signaling},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70305}
}
EUVIMED